Figures & data
Figure 1. The possible enablers of patient-centered, holistic approach to palliative care for people with Parkinson’s during the COVID-19 pandemic. NMS – Non-motor symptoms, PwP – People with Parkinson’s
![Figure 1. The possible enablers of patient-centered, holistic approach to palliative care for people with Parkinson’s during the COVID-19 pandemic. NMS – Non-motor symptoms, PwP – People with Parkinson’s](/cms/asset/42f60eb2-f187-45a7-abb1-8fa7c8a18825/iern_a_1923480_f0001_oc.jpg)
Figure 2. Prevention and management of delirium, both hypo- and hyperactive, in PwP affected by COVID-19. DRT – dopamine replacement therapy, ACB – Acetylcholine cognitive burden scale
![Figure 2. Prevention and management of delirium, both hypo- and hyperactive, in PwP affected by COVID-19. DRT – dopamine replacement therapy, ACB – Acetylcholine cognitive burden scale](/cms/asset/7696a603-8d60-46cf-93f0-7d4ae5eaaa5f/iern_a_1923480_f0002_oc.jpg)
Figure 3. Worsening of particular non-motor symptoms in PwP during the COVID-19 pandemic. PwP – People with Parkisnon’s, NMS - Non-motor symptoms,NMSQuest – Non-motor Symptoms Questionnaire
![Figure 3. Worsening of particular non-motor symptoms in PwP during the COVID-19 pandemic. PwP – People with Parkisnon’s, NMS - Non-motor symptoms,NMSQuest – Non-motor Symptoms Questionnaire](/cms/asset/1963a25d-5a65-436a-9c6b-977d2aa91829/iern_a_1923480_f0003_oc.jpg)